Antikoagulantien

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten


1 Bibliographie[Bearbeiten]

  1. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med 126(12):959-62 (1997) PMID 9182473
  2. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood 111(10):4871-9 (2008) PMID 18309033
  3. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood 111(9):4471-6 (2008) PMID 18316627
  4. New anticoagulants. Blood 105(2):453-63 (2005) PMID 15191946
  5. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):257S-298S (2008) PMID 18574268
  6. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):160S-198S (2008) PMID 18574265
  7. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 114(5 Suppl):445S-469S (1998) PMID 9822057
  8. Conundrums in the combined use of anticoagulants and antiplatelet drugs. Circulation 116(3):305-15 (2007) PMID 17638939
  9. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 3(5):1504-10 (2008) PMID 18495950
  10. Anticoagulants in heart disease: current status and perspectives. Eur Heart J 28(7):880-913 (2007) PMID 17426080
  11. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J 27(5):519-26 (2006) PMID 16143706
  12. Management of excessive anticoagulant effect due to vitamin K antagonists. Hematology Am Soc Hematol Educ Program ():266-70 (2008) PMID 19074094
  13. New anticoagulants in children. Hematology Am Soc Hematol Educ Program ():245-50 (2008) PMID 19074090
  14. Thrombophilia and new anticoagulant drugs. Hematology Am Soc Hematol Educ Program ():424-38 (2004) PMID 15561696
  15. Anticoagulation therapy. Hematology Am Soc Hematol Educ Program ():339-57 (2001) PMID 11722992
  16. Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question. Mayo Clin Proc 83(6):628-9 (2008) PMID 18533078
  17. Long-term anticoagulation. Indications and management. West J Med 151(4):414-29 (1989) PMID 2686173
  18. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. J Am Coll Cardiol 51(8):826-7 (2008) PMID 18294567
  19. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol 51(8):818-25 (2008) PMID 18294566

2 Andere Lexika[Bearbeiten]